Oleoyl ethyl amide

Oleoyl ethyl amide (N-Ethyloleamide) (0.3 mg/kg; i.v.; single administration; approximately 45 min) exhibits activity in increasing the voiding interval, voided volume, and bladder capacity in awake normal Sprague-Dawley rat models^[1].
Oleoyl ethyl amide (1-10 mg/L (perfused at 10 mL/h); intravesical administration; continuous perfusion for 45 min) exhibits dose-dependent activity in increasing the voiding interval, voided volume, and bladder capacity in conscious Sprague-Dawley rat models^[1].
Oleoyl ethyl amide (0.3 mg/kg; i.v.; single administration; 45 min) prolongs the intervoiding interval, bladder capacity, voided volume, and bladder compliance in a partially urethral obstructed (PUO) Sprague-Dawley rat model^[2].
Oleoyl ethyl amide (0.1-10 mg/kg; i.p.; single administration) exhibits activity in increasing the latency of Apomorphine (HY-12723)-induced ejaculation and decreasing the frequency of spontaneous seminal vesicle contractions in anesthetized male Sprague-Dawley rat ejaculation models^[4].
Oleoyl ethyl amide (0.75 mg/kg; i.p.; single administration) exhibits activity affecting bladder capacity (BC) and micturition volume (MV) via the TRPV1 pathway in a female rat model^[5].